Heart valve replacement safe in patients with enlarged aorta?

NCT ID NCT07148973

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 101 patients with severe aortic stenosis who had a minimally invasive heart valve replacement (TAVR). Researchers wanted to see if the procedure was safe for patients who also had an enlarged ascending aorta (≥40 mm). They compared outcomes like death rates between those with and without an enlarged aorta. The goal was to gather information to help guide future treatment decisions for this specific group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Transcatheter Aortic Valve Replacement (TAVR) procedure
What this could lead to
If successful, this study could help doctors better understand whether TAVR is safe for patients with an enlarged aorta, potentially expanding treatment options for this group.
What could go wrong
This is a small, single-center study with only 101 participants, so results may not apply to all patients. It is observational, so it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASCENDING AORTIC DILATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • the Affiliated Zhongshan Hospital of Dalian University

    Dalian, Liaoning, 116001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.